Autotaxin, Pruritus and Primary Biliary Cholangitis (PBC)

Area of Science:

• Biochemistry
• Enzymology
• Hepatology

Background:

• Autotaxin (ATX), also known as ENPP2, is an enzyme with pyrophosphatase/phosphodiesterase and lysophospholipase D (lysoPLD) activities.
• ATX is the sole producer of circulating lysophosphatidic acid (LPA), a signaling lipid involved in physiological and pathological processes.
• The ATX-LPA axis has been implicated in pruritus, particularly in chronic cholestatic liver diseases like primary biliary cholangitis (PBC).

Purpose of the Study:

• To review the biochemistry of Autotaxin (ATX).
• To explore the rationale behind ATX's role in pruritus.
• To highlight ATX as a potential therapeutic target for pruritus in PBC.

Main Methods:

• Review of existing scientific literature on Autotaxin (ATX) and its role in pruritus.
• Analysis of the biochemical properties of ATX, including its lysoPLD activity.
• Examination of the association between plasma ATX activity and pruritus in PBC patients.

Main Results:

• Autotaxin (ATX) possesses unique lysophospholipase D (lysoPLD) activity, converting lysophosphatidylcholine (LPC) to lysophosphatidic acid (LPA).
• Plasma ATX activity is strongly correlated with pruritus in patients with primary biliary cholangitis (PBC).
• ATX heterozygous mice exhibit reduced plasma LPA levels, supporting its role in LPA production.

Conclusions:

• The ATX-LPA signaling pathway is crucial in both normal physiology and disease.
• Plasma ATX activity is a significant indicator and potential driver of pruritus in PBC.
• Targeting ATX presents a promising therapeutic strategy for managing pruritus in chronic cholestatic liver diseases.